Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Intravitreal bevacizumab has been associated with significant early functional and anatomic improvements in macular edema. The authors of a recent prospective, nonrandomized, interventional study evaluated the early rate of change of best–corrected visual acuity, central retinal sensitivity, neuroretinal and choroidal thickness in patients with macular edema after injecting 1.25 mg/0.05 ml of intravitreal bevacizumab in 37 consecutive eyes that were afflicted.


Today in Clinical Pharmacology...keeping you current

Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09

Today in Retina...keeping you current

Value of retinal examination in hypertensive encephalopathy
Journal of Human Hypertension, 11/03/09

Retinopathy of Prematurity
NeoReviews, 11/04/09

Late Increased Risk of Retinal Detachment after Cataract Extraction
American Journal of Ophthalmology, 10/30/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address